Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of technology of hyperuricemia and composition, applied in the field of pharmaceutical compositions for treating hyperuricemia
Active Publication Date: 2006-10-18
中山市恒生药业有限公司
View PDF2 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, these drugs often have many diseases such as liver dysfunction, aplastic anemia, granulocytopenia, Smith-Johnson syndrome, neutrophil necrosis, allergic vasculitis, acute renal failure, interstitial pneumonia, rhabdomyolysis, etc. side effects, so it has become a development trend to find safe and effective traditional Chinese medicine preparations and other natural medicines
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Composition: Astragalus extract 165g (astragalus total saponin content ≥ 10%, astragaloside IV content ≥ 0.20%, hereinafter the same),
[0018] Cortex chinensis extract (total coumarin content of bark bark ≥ 50%, esculin content ≥ 5%, the same below) 66g,
[0020] Appropriate amount of excipients for conventional tablet preparations.
[0021] The above raw materials were mixed and granulated according to the conventional manufacturing process of oral tablets, and compressed into tablets to obtain 1000 tablets for oral administration.
Embodiment 2
[0023] Composition: Astragalus Extract 130g
[0024] Qin Bark Extract 66g
[0025] Tea Extract 15g
[0026] Appropriate amount of excipients for capsule preparation
[0027] The above raw materials are mixed and granulated according to the manufacturing process of conventional oral capsule medicine, and then packed into capsules to obtain 1000 capsules for oral administration.
Embodiment 3
[0029] Composition: Astragalus Extract 150g
[0030] Qin Bark Extract 66g
[0031] Tea Extract 10g
[0032] Appropriate amount of excipients for conventional oral liquid
[0033] Dissolve the above raw materials in distilled water, mix evenly according to the conventional oral liquid preparation manufacturing process, add flavoring agents, stabilizers, etc., and fill to obtain 1000 oral liquids.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The medicine composition for treating hyperuricemia consists of basic effective medicine components including astragalus root extract in 1-8 weight portions, cortex fraxini extract in 0.3-3 weight portions and tea extract in 0.1-2 weight portions, and pharmaceutically acceptable supplementary material. Of the basic effective medicine components, the astragalus root extract contains total astragaloside not less than 10 %, the cortex fraxini extract contains total cortex fraxini coumarin not less than 30 %,and the tea extract contains tea polyphenol not less than 50 %. The medicine composition may be prepared into common oral preparation or injection for controlling the acute attack of gouty arthritis, treating hyperuricemia and chronic uric acid type nephropathy, remitting arthralgia and promoting uric acid excretion.
Description
technical field [0001] The invention relates to a pharmaceutical composition which can be used for treating various diseases caused by hyperuricemia. Background technique [0002] Gout is a disease caused by purine metabolism disorder. The clinical features are hyperuricemia and the resulting gouty arthritis, chronic uric acid nephropathy, and kidney stones. In traditional Chinese medicine, it belongs to the category of arthralgia. At present, it is believed that the main causes of increased blood uric acid are: (1) increased production of uric acid in the body; (2) renal insufficiency, decreased renal excretion of uric acid; (3) both increased production and decreased excretion. At present, gout and hyperuricemia have become common diseases in middle-aged and elderly people. Especially with the continuous improvement of living standards, the number of clinical patients has also increased sharply. The current treatment of such diseases mainly adopts chemical drugs such as...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more